| First author | Year | Country | Age | Total Participant | Female | AC | HAM/TSP patients | ATLL | Control group | HLA typing method | HLA locus |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Alves [17] | 2016 | Brazil | 45.03 ± 13.91 | 235 | 145 | 45 | 37 | – | 153 | PCR | G |
2 | Catalan-Soares [15] | 2009 | Brazil | 48.9 ± 12.74 | 93 | 54 | 84 | 9 | – | – | SSP PCR | A, B, C |
3 | Deschamps [18] | 2010 | Martinique | 60 ± 1.43 | 208 | 162 | 85 | 123 | – | – | SSO PCR | A, B, DRB1, DQB1 |
4 | Elovaara [19] | 1993 | USA (Japanese, Jamaican, etc.) | 44.22 ± 10.81 | 9 | 7 | 5 | 4 | – | – | N/A | A, B, C, DRB1, DQB1 |
5 | Furukawa [20] | 2000 | Japan | N/A | 447 | N/A | 200 | 192 | 55 | – | PCR | A |
6 | Goedert [21] | 2007 | Jamaica | N/A | 610 | N/A | 380 | 118 | 112 | – | SSO PCR | A, B, DRB1, DQB1 |
7 | Haddad [23] | 2011 | Brazil | 44.69 ± 14.02 | 288 | 155 | 56 | 49 | 33 | 150 | PCR | G |
8 | Jeffery [24] | 1999 | Japan | 50.64 | 433 | 255 | 201 | 232 | – | – | SSP PCR | A, DRB1 |
9 | Jeffery [25] | 2000 | Japan | 50.64 | 433 | 255 | 201 | 232 | – | – | SSP PCR | A, B C |
10 | Kozako [26] | 2006 | Japan | 60.57 | 67 | 22 | 35 | – | 32 | – | SSO PCR | A |
11 | Lou [27] | 1998 | Russia (Nivkhi) | 38.66 | 57 | 29 | 4 | – | – | 53 | PCR | A, B, C, DRB1, DQB1 |
12 | Manns [28] | 1998 | Jamaica | 45 | 197 | 161 | 43 | 54 | 49 | 51 | SSO PCR | DRB1, DQB1 |
13 | Nishimura [29] | 2000 | Japan | N/A | 159 | N/A | 50 | 51 | 47 | 112 | PCR | DRB1 |
14 | Penova [30] | 2021 | Japan | N/A | 1652 | N/A | 899 | 753 | – | – | NGS | A, B, C, DQB1, DRB1 |
15 | Rafatpanah [31] | 2007 | Iran (Mashhad) | N/A | 142 | N/A | 34 | 36 | – | 72 | SSP PCR | A, B, C, DRB1 |
16 | Schor [32] | 2023 | Brazil | 61 | 375 | 222 | 165 | 210 | – | – | SSP and SSO PCR | A, B, C, DRB1 |
17 | Shohat [33] | 1996 | Israel (Mashhad-Japanese) | N/A | 48 | 24 | 7 | 12 | 1 | 28 | SSP PCR | A, B, DRB1, DQB1 |
18 | Tafreshian [34] | 2014 | Iran (Mashhad) | N/A | 66 | N/A | 20 | 16 | – | 30 | SSP PCR | HLA-DQB1 |
19 | Taghaddosi [35] | 2012 | Iran (Mashhad) | N/A | 50 | N/A | 30 | 20 | – | – | SSP PCR | A, B, C |
20 | Talledo [36] | 2010 | Peru | 47.44 | 165 | 102 | 94 | 71 | – | – | PCR | A, C |
21 | Tarokhian [37] | 2016 | Iran (Mashhad) | 42.67 ± 1.94 | 71 | N/A | 38 | 33 | – | – | SSP PCR | A, C |
22 | Treviño [38] | 2013 | Spain | N/A | 40 | N/A | 28 | 12 | – | – | NGS | A, B, C, DRB1, DQB1 |
23 | Study group [22] | 1988 | Japan | 56.9 | 404 | 115 | – | – | 64 | 340 | N/A | A, B, C |
24 | Vine [39] | 2002 | Japan | N/A | 431 | N/A | 202 | 229 | – | – | SSP PCR | A, B, C, DRB1 |
25 | Yashiki [40] | 2001 | Japan | N/A | 599 | N/A | 152 | 148 | 124 | 175 | SSP and SSO PCR | A, B, C |